Skip to main content

General Psychiatry

The opening session of the Cocaine, Meth & Stimulant Summit suggested a number of explanations for the worrisome trend of concurrent stimulant and opioid use.
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.
A report released today by Quest Diagnostics and the Center on Addiction shows some inconsistencies between physician perspectives and patient behaviors regarding prescription drug use.
Cognitive behavioral therapy (CBT) delivered via websites or mobile apps appears beneficial as an addition to usual care in specialty substance use settings or as standalone therapy for alcohol use.
The majority of studies included in a new literature review identified significant improvement in a variety of psychiatric disorders among patients who took hallucinogenic drugs.
Back to Top